170 related articles for article (PubMed ID: 33971040)
1. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
Boddicker NJ; Larson MC; Castellino A; Herrmann J; Inwards DJ; Thanarajasingam G; Maurer MJ; Allmer C; Witzig TE; Nowakowski GS; Habermann TM; Villarraga HR; Slager SL; Cerhan JR; Thompson CA
Am J Hematol; 2021 Aug; 96(8):979-988. PubMed ID: 33971040
[TBL] [Abstract][Full Text] [Related]
2. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
4. Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study.
Hamood R; Hamood H; Merhasin I; Keinan-Boker L
J Cardiol; 2019 Apr; 73(4):280-291. PubMed ID: 30587455
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.
Keegan THM; Kushi LH; Li Q; Brunson A; Chawla X; Chew HK; Malogolowkin M; Wun T
J Cancer Surviv; 2018 Jun; 12(3):388-397. PubMed ID: 29427203
[TBL] [Abstract][Full Text] [Related]
6. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study.
Hau EM; Caccia JN; Kasteler R; Spycher B; Suter T; Ammann RA; von der Weid NX; Kuehni CE
Swiss Med Wkly; 2019 Feb; 149():w20012. PubMed ID: 30852834
[TBL] [Abstract][Full Text] [Related]
9. Late cardiotoxicity after treatment for Hodgkin lymphoma.
Aleman BM; van den Belt-Dusebout AW; De Bruin ML; van 't Veer MB; Baaijens MH; de Boer JP; Hart AA; Klokman WJ; Kuenen MA; Ouwens GM; Bartelink H; van Leeuwen FE
Blood; 2007 Mar; 109(5):1878-86. PubMed ID: 17119114
[TBL] [Abstract][Full Text] [Related]
10. The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression.
Wollersheim BM; Boekhout AH; van der Poel HG; van de Poll-Franse LV; Schoormans D
BJU Int; 2020 Mar; 125(3):433-441. PubMed ID: 31773851
[TBL] [Abstract][Full Text] [Related]
11. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.
Salz T; Zabor EC; de Nully Brown P; Dalton SO; Raghunathan NJ; Matasar MJ; Steingart R; Vickers AJ; Svenssen Munksgaard P; Oeffinger KC; Johansen C
J Clin Oncol; 2017 Dec; 35(34):3837-3843. PubMed ID: 28922087
[TBL] [Abstract][Full Text] [Related]
12. Midlife Ankylosing Spondylitis Increases the Risk of Cardiovascular Diseases in Males 5 Years Later: A National Population-Based Study.
Hung YM; Chang WP; Wei JC; Chou P; Wang PY
Medicine (Baltimore); 2016 May; 95(18):e3596. PubMed ID: 27149491
[TBL] [Abstract][Full Text] [Related]
13. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
14. Incident Cardiovascular Diseases Among Survivors of High-Risk Stage II-III Colorectal Cancer: A Cluster-Wide Cohort Study.
Lee SF; Yip PL; Vellayappan BA; Chee CE; Wong LC; Wan EY; Chan EW; Lee CF; Lee FA; Luque-Fernandez MA
J Natl Compr Canc Netw; 2022 Oct; 20(10):1125-1133.e10. PubMed ID: 36240841
[TBL] [Abstract][Full Text] [Related]
15. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.
Pinder MC; Duan Z; Goodwin JS; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3808-15. PubMed ID: 17664460
[TBL] [Abstract][Full Text] [Related]
16. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.
Newman AB; Spiekerman CF; Enright P; Lefkowitz D; Manolio T; Reynolds CF; Robbins J
J Am Geriatr Soc; 2000 Feb; 48(2):115-23. PubMed ID: 10682939
[TBL] [Abstract][Full Text] [Related]
17. The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.
Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
J Natl Cancer Inst; 2019 Aug; 111(8):854-862. PubMed ID: 30715404
[TBL] [Abstract][Full Text] [Related]
18. Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
Baech J; Hansen SM; Lund PE; Soegaard P; Brown PN; Haaber J; Jørgensen J; Starklint J; Josefsson P; Poulsen CB; Juul MB; Torp-Pedersen C; El-Galaly TC
Br J Haematol; 2018 Dec; 183(5):717-726. PubMed ID: 30406945
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study.
Lee SF; Vellayappan BA; Wong LC; Chiang CL; Chan SK; Wan EY; Wong IC; Lambert PC; Rachet B; Ng AK; Luque-Fernandez MA
ESMO Open; 2022 Feb; 7(1):100363. PubMed ID: 35026723
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.
Lubberts S; Groot HJ; de Wit R; Mulder S; Witjes JA; Kerst JM; Groenewegen G; Lefrandt JD; van Leeuwen FE; Nuver J; Schaapveld M; Gietema JA
J Clin Oncol; 2023 Jul; 41(19):3512-3522. PubMed ID: 37071834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
